Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: Experience of a high-volume center

Minerva Cardioangiologica

Volumn 56, Issue 4, 2008, Pages 391-399

  Vecchio, S ^a   Chechi, T ^a   Giuliani, G ^a   Lilli, A ^a   Consoli, L ^a   Spaziani, G ^a   Giannotti, F ^a   Margheri, M ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiac surgical procedures; Heart assist devices; Shock, cardiogenic

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEASIBILITY STUDY; FOLLOW UP; HEART ASSIST DEVICE; HEART LEFT VENTRICLE; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; IMPLANTATION; KIDNEY FAILURE; MALE; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; THROMBOCYTOPENIA;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEASIBILITY STUDIES; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 52449085765     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Briguori C, Sarais C, Pagnotta P, Airoldi F, Liistro F, Sgura F et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J 2003;145:700-707.
2. Hochman JS, Buller CE, Sleeper LA, Boland J, Dzavik V, Sanborn TA et al. Cardiogenic shock complicatine acute myocardial infarction - etiologies, management and outcome: a report from SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36(3 Suppl A): 1003-70.
3. Argon J, Lee MS, Kar S, Makkar RR. Percutaneous left ventricular assist device: "TandemHeart" for high risk coronary intervention. Cath Cardiovasc Int 2005;65:346-52.
4. Ferrari M, Aboulhosn W, Figulla HR. Successful high-risk coronary angioplasty in a patient with cardiogenic shock under circulatory assist with a 16F axial flow pump. Cath Cardiovasc Int 2005;66:557-61.
5. Valgimigli M, Steendijk P, Sianos G, Onderwater E, Serruys PW. Left ventricular unloading and concomitant total cardiac output increase by the use of percutaneous impella recover LP 2.5 assist device during high-risk coronary intervention. Cath Cardiovasc Int 2005;65:263-7.
6. Lemos PA, Cummins P, Lee CH, Degertekin M, Gardien M, Ottervanger JP et al. Usefulness of percutaneous left ventricular assitance to support high-risk percutaneous coronary interventios. Am J Cardiol 2003;91:479-81.
7. Scholz KH, Dubois-Rande JL, Urban P, Morice MC, Loisance D, Smalling RW et al. Clinical experience with the percutaneous hemopump during high-risk coronary angioplasty. Am J Cardiol 1998;45:115-9.
8. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9-13.
9. Singh M, Rihak C, Selzer F, Kip KE, Detre K, Holmes DR. Validation of Mayo Clinic Risk adjustment model for in-hospital complications after percutaneous coronary interventions , using the National Heart, Lung, and Blood Institute Dynamic Registry. J Am Coll Cardiol 2003;42:1722-8.
10. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
11. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an InTIME II trial substudy. Circulation 2000;102:2031-7.
12. Meyns B, Sergeant P, Wouters P, Casselman F, Herijgers P, Daenen W et al. Mechanical support with microaxial blood pumps for postcardiotomy left ventricular failure: can outcome be predicted? J Thorac Cardiovasc Surg 2000;120:393-400.
13. Von Segesser LK. Cardiopulmonary support and extracorporeal membrane oxygenator for cardiac assist. Ann Thorac Surg 1999;68:672-7.
14. Doll N, Kiaii B, Borger M, Bucerius J, Kramer K, Schmitt DV et al. Five-year results of 219 consecutive patients trated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004;77:151-7.
15. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001;104:2917-22.
16. Valgimigli M, steendijk P, Serruys PW, Vranckx P, Boomsma F, underwater E et al. Use of Impella Recover LP 2.5 left ventricular assist device during high-risk percutaneous coronary interventions: clinical, haemodynamic and biochemical findings. Eurointervention 2006;2:91-100.
17. Henriques JPS, Remmelink M, Baan J, van der Schaaf RJ, Vis MM, Koch KT et al. Safety and feasibility of elective highrisk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 2006;97:990-2.
18. Stegmayr B. Apheresis of plasma compounds as s therapeutic principle in severe sepsis and multiorgan dysfunction syndrome. Clin Chem Lab Med 1999;37:327-32.
19. Tayara W, starling RC, Yamani MH, Wazni O, Jubran F, Smedira N. Improved survival after acute myocardial infarction complicated by cardiogenic shock with circulatory support and transplantation: comparing aggressive intervention with conservative treatment. J Heart Lung Transplant 2006;25:504-9.
20. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26:1276-83.
21. Burkhoff D, Cohen H, Brunckhorst C, O'Neill WW; TandemHeart Investigators group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006;152:469.e1-469.e8.
22. Dens J, Meyns B, Hilgers RD, Maessend J, van Ommen V, Gerckens U et al. First experience with the Impella recover LP 2.5 micro axial pump in patients with cardiogenic shock or undergoing high-risk revascularization. EuroInterv 2006;2:84-90.